thiophenes has been researched along with Hallux Valgus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burt, DA; Farrell, C; Fossler, MJ; Pitsiu, M; Sadler, BM; Skobieranda, F; Soergel, DG | 1 |
| Bolognese, JA; Cook, E; Daniels, S; Kuss, M; Skobieranda, F; Soergel, DG; Subach, RA; Viscusi, ER; Webster, L; Zuckerman, S | 1 |
2 trial(s) available for thiophenes and Hallux Valgus
| Article | Year |
|---|---|
Oliceridine (TRV130), a Novel G Protein-Biased Ligand at the μ-Opioid Receptor, Demonstrates a Predictable Relationship Between Plasma Concentrations and Pain Relief. I: Development of a Pharmacokinetic/Pharmacodynamic Model.
Topics: Adult; Aged; Cytochrome P-450 CYP2D6; Double-Blind Method; Female; Hallux Valgus; Humans; Male; Middle Aged; Models, Biological; Pain; Pain Measurement; Pain, Postoperative; Spiro Compounds; Thiophenes; Treatment Outcome; Young Adult | 2018 |
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain.
Topics: Acute Pain; Adolescent; Adult; Aged; Analgesics, Opioid; Double-Blind Method; Female; Hallux Valgus; Humans; Male; Middle Aged; Morphine; Orthopedic Procedures; Receptors, Opioid, mu; Spiro Compounds; Thiophenes; Treatment Outcome; Young Adult | 2016 |